Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Good
|
New words:
ablation, advisory, AML, appraisal, autoimmune, brand, Charlottetown, Cholestagel, clofarabine, Connecticut, DCL, delisted, dissenting, division, easier, Edinburgh, Edward, Evoltra, FDAAA, gave, goal, headcount, hyperphosphatemia, hyperphosphatemic, infection, Investee, Investor, Island, lymphoeytic, Lyon, mitigation, myeloid, nasdaq, nonrefundable, ofSettlement, Pasteur, Prince, proportional, proportionate, remnant, rendered, rim, Sanofi, Scotland, software, South, sterling, supplemental, Westborough, Wichita
Filing tables
Filing exhibits
Related press release
GZTR similar filings
Filing view
External links